Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production
Highlights • Riluzole leads to a suppression of cell proliferation in liver cancer cells. • Riluzole induced caspase-dependent apoptosis and G2/M cell cycle arrest. • Riluzole-treated cells have increased level of inner cellular glutamate • Riluzole-treated cells have decrease the glutathione (GSH)...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2016-11, Vol.382 (2), p.157-165 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Riluzole leads to a suppression of cell proliferation in liver cancer cells. • Riluzole induced caspase-dependent apoptosis and G2/M cell cycle arrest. • Riluzole-treated cells have increased level of inner cellular glutamate • Riluzole-treated cells have decrease the glutathione (GSH) level and increase reactive oxygen species (ROS) production. • Riluzole-induced GSH and ROS changes in a Huh7 xenograft cancer model. |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/j.canlet.2016.08.028 |